'Liquid biopsy' may help earlier detection of lung cancer treatment resistance

Share :
Published: 13 May 2015
Views: 2945
Rating:
Save
Dr Jonas Nilsson - Umeå University, Umeå, Sweden

Dr Nilsson talks to ecancertv at AACR 2015 about the development of a blood test which regularly monitors for the presence of the rearrangement of the EML4-ALK gene fusion in patients with non-small cell lung cancer (NSCLC), helping clinicians predict the outcome of treatment with crizotinib.

Read the news story for more.